Trial intelligence / Profile preview

Understanding the Role of Inflammation in Alcohol Use Disorder Using an Endotoxin Challenge

NCT07452146Phase 2Not yet recruiting

Sponsor
University of California, Los Angeles
Start
Sep 2026
Primary completion
Sep 2028
Modality
Biologic
01

Overview

A Phase 2 trial of lipopolysaccharide endotoxin in alcohol use disorder (AUD), sponsored by University of California, Los Angeles. Planned start Sep 2026; status: not yet recruiting.

02

Drugs

lipopolysaccharide endotoxin
03

Conditions

alcohol use disorder (AUD)

Beyond the preview

Go deeper on NCT07452146.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07452146.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call